KT invests in vocal biomarker specialist in U.S.
KT will invest $2 million in Sonde Health, a U.S. tech company specializing in voice recognition technology for vocal biomarkers, for an unspecified stake, the telco said Thursday. Vocal biomarkers are signs of changes in the voice — the ...